Cargando…

The Potential of CAR T Cell Therapy in Pancreatic Cancer

Pancreatic cancer has a dismal prognosis and effective treatment options are limited. It is projected to be the second most common cause of cancer related mortality in the United States by 2030 and there is urgent unmet need for novel systemic treatment options. Immunotherapy with antibodies targeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akce, Mehmet, Zaidi, Mohammad Y., Waller, Edmund K., El-Rayes, Bassel F., Lesinski, Gregory B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167429/ https://www.ncbi.nlm.nih.gov/pubmed/30319627 http://dx.doi.org/10.3389/fimmu.2018.02166

Ejemplares similares

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
por: Sahin, Ibrahim Halil, et al.
Publicado: (2019)

Frontline therapy for advanced hepatocellular carcinoma: an update
por: Akce, Mehmet, et al.
Publicado: (2022)

Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
por: Ware, Michael Brandon, et al.
Publicado: (2020)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma
por: Ravindranathan, Sruthi, et al.
Publicado: (2022)

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer
por: Akce, Mehmet, et al.
Publicado: (2023)

Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022)

Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022)

Nonbacterial Thrombotic Endocarditis and Widespread Skin Necrosis in Newly Diagnosed Lung Adenocarcinoma
por: Zakka, Katerina, et al.
Publicado: (2020)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)

Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study
por: Atallah, Rami P., et al.
Publicado: (2022)

Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status
por: Akce, Mehmet, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies
por: Zhang, Xiaomin, et al.
Publicado: (2023)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies–Results from the CARE registry
por: Clausing, Daniel, et al.
Publicado: (2023)

Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival
por: Alese, Olatunji B., et al.
Publicado: (2021)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Ferreira, Leonardo M. R., et al.
Publicado: (2021)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

Advances in Universal CAR-T Cell Therapy
por: Lin, Haolong, et al.
Publicado: (2021)

Reactions Related to CAR-T Cell Therapy
por: Miao, Lele, et al.
Publicado: (2021)

Recent advances in CAR-T cells therapy for colorectal cancer
por: Qin, Xiaoling, et al.
Publicado: (2022)

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
por: Zakka, Katerina, et al.
Publicado: (2019)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
por: Ruppel, Katharina Eva, et al.
Publicado: (2022)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
por: Watanabe, Keisuke, et al.
Publicado: (2018)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
por: Jeyakumar, Nikeshan, et al.
Publicado: (2022)

Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device
por: Chu, Chia-Heng, et al.
Publicado: (2021)

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms
por: Zakka, Katerina, et al.
Publicado: (2020)

Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
por: Dwivedi, Alka, et al.
Publicado: (2019)

Advances in Developing CAR T-Cell Therapy for HIV Cure
por: Qi, Jinxin, et al.
Publicado: (2020)

Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
por: Lindo, Lorenzo, et al.
Publicado: (2021)

The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
por: Guo, Zilong, et al.
Publicado: (2021)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

Prospective approaches to enhancing CAR T cell therapy for glioblastoma
por: Choi, Sun Il, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5nltif4059re0v7uvjqnkr7cs